Abstract
MicroRNA (miRNA) plays a key role in the proliferation and invasion of vascular smooth muscle cells (VSMCs). However, the role and underlying mechanism of miRNAs in VSMCs are not fully understood. Therefore, this study was designed to investigate the role and mechanism of microRNA-1246 (miR-1246) in VSMCs. VSMCs were cultured, and the proliferation of VSMCs was stimulated by platelet-derived growth factor (PDGF-BB) or 15% fetal bovine serum (FBS). The quantitative reverse transcription PCR (qRT-PCR) was used to detect the expression levels of miR-1246 and cystic fibrosis transmembrane conductance regulator (CFTR) in VSMCs. The CCK-8 assay and transwell assay were used to detect the proliferation and invasion of VSMCs. Target gene prediction and screening and luciferase reporter assays were used to verify downstream target genes of miR-1246. Western blotting was used to detect the protein expression levels of PCNA, α-SMA, SM-MHC, Collagen-1, and Cyclin D1 in VSMCs. PDGF-BB and FBS treatment induced VSMCs proliferation and the upregulation of miR-1246 expression. Overexpression of miR-1246 promoted VSMCs proliferation, invasion, and differentiation towards synthetic phenotype, while knockdown of miR-1246 had opposite effects. In addition, CFTR was found to be a direct target for miR-1246, and miR-1246 inhibited the expression of CFTR. Moreover, overexpression of CFTR inhibited VSMC proliferation and synthetic differentiation, while overexpression of miR-1246 partly abolished the effects of CFTR overexpression on VSMCs proliferation and differentiation. Our data suggest that MiR-1246 promotes VSMC proliferation, invasion, and differentiation to synthetic phenotype by regulating CFTR. MiR-1246 may be a potential therapeutic target for atherosclerosis.
Similar content being viewed by others
References
Albinsson S, Sward K (2013) Targeting smooth muscle microRNAs for therapeutic benefit in vascular disease. Pharmacol Res 75:28–36. https://doi.org/10.1016/j.phrs.2013.04.003
Barranco C (2018) Atherosclerosis linked to faulty DNA repair in VSMCs. Nat Rev Cardiol 15:380. https://doi.org/10.1038/s41569-018-0021-0
Bonomini F, Taurone S, Parnigotto P, Zamai L, Rodella LF, Artico M, Rezzani R (2017) Role of parnaparin in atherosclerosis. Int J Exp Pathol 97:457–464
Cai W-L, Huang W-D, Li B, Chen T-R, Li Z-X, Zhao C-L, Li H-Y, Wu Y-M, Yan W-J, Xiao J-R (2018) microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11. Mol Cancer 17:9
Cao Q, Jiang Y, Shi J, Xu C, Liu X, Yang T, Fu P, Niu T (2015) Artemisinin inhibits the proliferation, migration, and inflammatory reaction induced by tumor necrosis factor-α in vascular smooth muscle cells through nuclear factor kappa B pathway. J Surg Res 194:667–678. https://doi.org/10.1016/j.jss.2014.12.013
Chen Q, Lin G, Huang J, Chen G, Huang X, Lin Q (2018) Expression profile of long non-coding RNAs in rat models of OSA-induced cardiovascular disease: new insight into pathogenesis. Sleep Breath 23:795–804. https://doi.org/10.1007/s11325-018-1753-0
Cheng CI, Lee YH, Chen PH, Lin YC, Chou MH, Kao YH (2017) Free fatty acids induce autophagy and LOX-1 upregulation in cultured aortic vascular smooth muscle cells. J Cell Biochem 118:1249–1261. https://doi.org/10.1002/jcb.25784
Emini Veseli B, Perrotta P, De Meyer GRA, Roth L, Van der Donckt C, Martinet W, De Meyer GRY (2017) Animal models of atherosclerosis. Eur J Pharmacol 816:3–13. https://doi.org/10.1016/j.ejphar.2017.05.010
Gebert LFR, MacRae IJ (2019) Regulation of microRNA function in animals. Nat Rev Mol Cell Biol 20:21–37. https://doi.org/10.1038/s41580-018-0045-7
Gelfond D, Heltshe S, Ma C, Rowe SM, Frederick C, Uluer A, Sicilian L, Konstan M, Tullis E, Roach RN, Griffin K, Joseloff E, Borowitz D (2017) Impact of CFTR modulation on intestinal pH, motility, and clinical outcomes in patients with cystic fibrosis and the G551D mutation. Clin Transl Gastroenterol 8:e81. https://doi.org/10.1038/ctg.2017.10
Gerdts V, Wilson HL, Meurens F, van Drunen Littel-van den Hurk S, Wilson D, Walker S, Wheler C, Townsend H, Potter AA (2015) Large animal models for vaccine development and testing. ILAR J 56:53–62. https://doi.org/10.1093/ilar/ilv009
Gokce A, Gul D, Halis F, Cimen HI (2017) P19 - M470V polymorphism in the cystic fibrosis transmembrane conductance regulator (CFTR) gene and male infertility. Eur Urol Suppl 16:e3011. https://doi.org/10.1016/S1569-9056(17)32139-5
Gwozdz T, Dorey K (2017) Western blot. In: TALALI M,SALDANHA F YL,JALALI M. Basic Science Methods for Clinical Researchers. Academic Press. 99-117.
Huhtinen A, Hongisto V, Laiho A, Loyttyniemi E, Pijnenburg D, Scheinin M (2017) Gene expression profiles and signaling mechanisms in alpha2B-adrenoceptor-evoked proliferation of vascular smooth muscle cells. BMC Syst Biol 11:65. https://doi.org/10.1186/s12918-017-0439-8
Kelnar K, Bader AG (2015) A qRT-PCR method for determining the biodistribution profile of a miR-34a mimic. Methods Mol Biol 1317:125–133. https://doi.org/10.1007/978-1-4939-2727-2_8
Kiyan Y, Fuhrman B, Haller H, Dumler I (2014) Vascular aging: revealing the role and clinical perspectives of the urokinase system. In: Leist A., Kulmala J., Nyqvist F. (eds) Health and Cognition in Old Age. International Perspectives on Aging, vol 10. Springer, Cham. https://doi.org/10.1007/978-3-319-06650-9_2
Kym PR, Wang X, Pizzonero M, Van der Plas SE (2018) Recent progress in the discovery and development of small-molecule modulators of CFTR. Prog Med Chem 57:235–276. https://doi.org/10.1016/bs.pmch.2018.01.001
Lee YT, Lin HY, Chan YW, Li KH, To OT, Yan BP, Liu T, Li G, Wong WT, Keung W, Tse G (2017) Mouse models of atherosclerosis: a historical perspective and recent advances. Lipids Health Dis 16:12. https://doi.org/10.1186/s12944-016-0402-5
Lehners M, Dobrowinski H, Feil S, Feil R (2018) cGMP signaling and vascular smooth muscle cell plasticity. J Cardiovasc Dev Dis 5. https://doi.org/10.3390/jcdd5020020
Li W, Wang C, Peng X, Zhang H, Huang H, Liu H (2018) CFTR inhibits the invasion and growth of esophageal cancer cells by inhibiting the expression of NF-κB. Cell Biol Int 42:1680–1687. https://doi.org/10.1002/cbin.11069
Li XJ, Ren ZJ, Tang JH, Yu Q (2017) Exosomal microRNA MiR-1246 promotes cell proliferation, invasion and drug resistance by targeting CCNG2 in breast cancer. Cell Physiol Biochem 44:1741–1748. https://doi.org/10.1159/000485780
Lima C, Gomes C, Santos M (2017) Role of microRNAs in endocrine cancer metastasis. Mol Cell Endocrinol 456:62–75. https://doi.org/10.1016/j.mce.2017.03.015
Lin SS, Peng CY, Liao YW, Chou MY, Hsieh PL, Yu CC (2018) miR-1246 targets CCNG2 to enhance cancer stemness and chemoresistance in oral carcinomas. Cancers (Basel) 10:272. https://doi.org/10.3390/cancers10080272
Meng X, Clews J, Kargas V, Wang X, Ford RC (2017) The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability. Cell Mol Life Sci 74:23–38. https://doi.org/10.1007/s00018-016-2386-8
Pan J, Lu L, Wang X, Liu D, Tian J, Liu H, Zhang M, Xu F, An F (2018) AIM2 regulates vascular smooth muscle cell migration in atherosclerosis. Biochem Biophys Res Commun 497:S0006291X18303231
Peitzman ER, Gradworks T (2014) Adrenergic regulation of CFTR-dependent anion secretion and cell migration in airway epithelial cells. Dissertations
Ran L-J, Liang J, Deng X (2017) MicroRNAs regulate hepatic fibrosis via TGF-β/Smad pathway. World Chinese Journal of Digestology 25:166. https://doi.org/10.11569/wcjd.v25.i2.166
Saint-Criq V, Gray MA (2017) Role of CFTR in epithelial physiology. Cell Mol Life Sci 74:93–115. https://doi.org/10.1007/s00018-016-2391-y
Tian H, Ketova T, Hardy D, Xu X, Gao X, Zijlstra A, Blobe GC (2017) Endoglin mediates vascular maturation by promoting vascular smooth muscle cell migration and spreading. Arterioscler Thromb Vasc Biol 37:1115–1126. https://doi.org/10.1161/ATVBAHA.116.308859
Wang H, Jiang M, Xu Z, Huang H, Gong P, Zhu H, Ruan C (2015) miR-146b-5p promotes VSMC proliferation and migration. Int J Clin Exp Pathol 8:12901–12907
Wu K, He J, Pu W, Peng Y (2018) The role of exportin-5 in microRNA biogenesis and cancer. Genom Proteom Bioinf 16:120–126. https://doi.org/10.1016/j.gpb.2017.09.004
Wu Z, Li J, Zhang Y, Hu L, Peng X (2020) CFTR regulates the proliferation, migration and invasion of cervical cancer cells by inhibiting the NF-kappaB signalling pathway. Cancer Manag Res 12:4685–4697. https://doi.org/10.2147/CMAR.S252296
Xiao XL, Hu N, Zhang XZ, Jiang M, Chen C, Ma R, Ma ZG, Gao JL, Xuan XC, Sun ZJ, Dong DL (2018) Niclosamide inhibits vascular smooth muscle cell proliferation and migration and attenuates neointimal hyperplasia in injured rat carotid arteries. Br J Pharmacol 175:1707–1718. https://doi.org/10.1111/bph.14182
Xie C, Jiang XH, Zhang JT, Sun TT, Dong JD, Sanders AJ, Diao RY, Wang Y, Fok KL, Tsang LL, Yu MK, Zhang XH, Chung YW, Ye L, Zhao MY, Guo JH, Xiao ZJ, Lan HY, Ng CF, Lau KM, Cai ZM, Jiang WG, Chan HC (2013) CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer. Oncogene 32:2282–2291, 2291 e2281-2287. https://doi.org/10.1038/onc.2012.251
Yang F, Chen Q, He S, Yang M, Maguire EM, An W, Afzal TA, Luong LA, Zhang L, Xiao Q (2018) miR-22 is a novel mediator of vascular smooth muscle cell phenotypic modulation and neointima formation. Circulation 137:1824–1841. https://doi.org/10.1161/CIRCULATIONAHA.117.027799
Yang F, Xiao Q (2016) 197 miRNA-22 regulates vascular smooth muscle cell functions and prevents neointima formation by targeting EVI-1. Heart 102:A132.133–A132A133
Ying SY, Chang DC, Lin SL (2013) The microRNA. Methods Mol Biol 936:1–19. https://doi.org/10.1007/978-1-62703-083-0_1
Zafari S, Backes C, Leidinger P, Meese E, Keller A (2015) Regulatory microRNA networks: complex patterns of target pathways for disease-related and housekeeping microRNAs. Genomics Proteomics Bioinformatics 13:159–168. https://doi.org/10.1016/j.gpb.2015.02.004
Zhang JR, Lu QB, Feng WB, Wang HP, Tang ZH, Cheng H, Du Q, Wang YB, Li KX, Sun HJ (2018) Nesfatin-1 promotes VSMC migration and neointimal hyperplasia by upregulating matrix metalloproteinases and downregulating PPARgamma. Biomed Pharmacother 102:711–717. https://doi.org/10.1016/j.biopha.2018.03.120
Zhang Q, Cao LY, Cheng SJ, Zhang AM, Jin XS, Li Y (2015) p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB. Oncol Rep 33:1335–1341. https://doi.org/10.3892/or.2015.3715
Zhen X (2016) Analysis of the expression of miRNAs and downstream target genes in gastric cancer tissue and exploration of its relationship with clinicopathologic stage. J Hainan Med Univ 22:5–8
Zhou X, Du YL, Jin P, Ma F (2015) Bioinformatic analysis of cancer-related microRNAs and their target genes. Yi Chuan 37:855–864. https://doi.org/10.16288/j.yczz.14-439
Zou Y, Chen Z, Jennings BL, Zhao G, Gu Q, Bhattacharya A, Cui Y, Yu B, Malik KU, Yue J (2018) Deletion of DGCR8 in VSMCs of adult mice results in loss of vascular reactivity, reduced blood pressure and neointima formation. Sci Rep 8:1468. https://doi.org/10.1038/s41598-018-19660-z
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval and consent to participate
Not applicable.
Informed consent
Not applicable.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
A Commentary to this article is available online at https://doi.org/10.1007/s00424-021-02516-3
Rights and permissions
About this article
Cite this article
Pan, D., Liu, G., Li, B. et al. MicroRNA-1246 regulates proliferation, invasion, and differentiation in human vascular smooth muscle cells by targeting cystic fibrosis transmembrane conductance regulator (CFTR). Pflugers Arch - Eur J Physiol 473, 231–240 (2021). https://doi.org/10.1007/s00424-020-02498-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-020-02498-8